: iStockAnalyst.com Symbols Feed

Weekly Stock Watch Bullish Breakout Stocks on BIG Volume

Fri, 24 Jul 2009 04:59:57 GMT

In this post I'll name 15 stocks I think are worthy of adding to the stock watch list and some I may be speculating with in the weeks to come. I'm a firm believer of stocks which have had significant moves higher, on big volume, and these are the stocks..[More...]

Analyst Comments: Garmin, Acergy, PeopleSupport, Calgon Carbon, Weatherford, Scientific Games, Philip Morris, Cleveland Bio

Tue, 30 Sep 2008 12:42:00 GMT

Garmin, Ltd. (GRMN) is an OEM (original equipment manufacturer) of GPS-based equipment. June quarter results were short of the consensus on both the top and bottom lines. All segments were up double-digits in 2007, and are expected to be up again in 2008. Pricing pressures continue to intensify, however, negating some of the growth in units. Management is optimistic about material prices offsetting ASP pressures in 2008. We see increasing revenue and gradually decreasing profitability for the company. However, being a market leader, the company should fare better than most of the other smaller players. Consequently, we view the declining share price as an opportunity to accumulate shares. We reiterate our BUY rating. Sejuti Banerjea contributed to this report. [More...]

Analyst Comments: Nat'l Oilwell Varco, Focus Media, Cleveland BioLabs, Nippon Telegraph, Oplink, Citi Trends

Fri, 22 Aug 2008 12:39:00 GMT

We are maintaining our Buy recommendation on National-Oilwell Varco, Inc. (NOV) shares, given its strong leverage to the current rig construction cycle. Despite the recent commodity-price weakness, demand continues to remain robust. We believe that oil pr[More...]

Analyst Comments: Logitech, Polycom, Cleveland BioLabs, Stryker, Wilmington

Fri, 18 Jul 2008 21:18:00 GMT

Logitech International S.A. (LOGI) reported revenues for the fourth quarter of 2008, which were better than expected although earnings were below our estimates due to write-down of value of remaining CDOs. The company delivered good quarter in terms of revenues despite weaknesses in its Cordless Keyboard and Gaming segments. There was strong demand for Harmony remotes and pointing devices combined with good traction in original equipment manufacturer. Gross margins remained at a high level for the company reflecting ongoing product cost reductions and supply chain efficiencies. We now estimate that the company will continue to grow revenues and GAAP EPS by 15.0% and 10.1% respectively in 2009 over 2008 figures. We expect the company to continue to take advantage of the leveraging of its cost efficiency, and our estimates may prove conservative if the audio, video and[More...]

Analyst Comments: Dollar Financial, Cleveland BioLabs, Methanex, Gerdau S.A., Broadcom, Mylan, PALM

Tue, 20 May 2008 22:19:15 GMT

Dollar Financial's (DLLR) 3Q08 (ended March 31, 2008) diluted earnings of $0.56 per share, were two cents short of our estimates as well as the consensus. Consolidated revenues were up 26.4% and net income increased by 18.3%, based on strong growth in Canada and the U.K. markets. The bottom-line results were partly offset by higher store and regional expenses, reflecting continued expansion and...[More...]

Jobs Report - Jan 4 2008 10:29AM

Fri, 04 Jan 2008 14:24:00 GMT

Good morning. A weaker than expected jobs report showing only 18,000 jobs and a higher unemployment rate at 5% have set a negative tone for the market. Although expectations for a friendly Fed will likely increase, so will anticipation for recession. At 10:AM we have ISM non-manufacturing survey. [More...]

Big Rebound Puts Some Spring Back in Local Stocks: Buffalo Portfolio Gained 17.6 Percent As Market Rallied in the Second Quarter

Sun, 05 Jul 2009 15:49:00 GMT

Jul. 5--After two devastating quarters as the stock market tanked, the Buffalo Portfolio of locally based stocks really needed a big shot in the arm.
The stocks of companies based in the Buffalo Niagara region had their best quarter in 12 years this spring, shooting up by 17.6 percent.
But the big second-quarter gain erased only a small portion of the pain that investors have endured since the financial crisis hit with full force last September and the recession began to exact a greater toll on the overall economy.

: iStockAnalyst.com Symbols Feed

Weekly Stock Watch Bullish Breakout Stocks on BIG Volume

Analyst Comments: Garmin, Acergy, PeopleSupport, Calgon Carbon, Weatherford, Scientific Games, Philip Morris, Cleveland Bio

Analyst Comments: Nat'l Oilwell Varco, Focus Media, Cleveland BioLabs, Nippon Telegraph, Oplink, Citi Trends

Analyst Comments: Logitech, Polycom, Cleveland BioLabs, Stryker, Wilmington

Analyst Comments: Dollar Financial, Cleveland BioLabs, Methanex, Gerdau S.A., Broadcom, Mylan, PALM

Jobs Report - Jan 4 2008 10:29AM

Big Rebound Puts Some Spring Back in Local Stocks: Buffalo Portfolio Gained 17.6 Percent As Market Rallied in the Second Quarter

Big Rebound Puts Some Spring Back in Local Stocks: Buffalo Portfolio Gained 17.6 Percent As Market Rallied in the Second Quarter

Cleveland BioLabs Nears Big Investment

Cleveland BioLabs Raises $2.9 Million

BRIEF: Cleveland BioLabs Raises Money for Radiation Medicine

Local Stocks Drop 31.1% in 2008 ; Only 3 of 22 End Year With a Gain

Local Stocks Drop 31.1% in 2008

Cleveland BioLabs Receives First U.S. Patent Allowance for Its Radiation Protection Drug Protectan CBLB502

Department of Defense Releases Further Funding to Cleveland BioLabs Under $8.8 Million Contract for Development Studies on Protectan CBLB502

Cleveland BioLabs Management Reviews Recent Highlights and Milestones at Annual Meeting

Cleveland BioLabs Concludes Initial Phase I Safety and Tolerability Study for CBLB502

Cleveland BioLabs Submits Response to Department of Defense Sources Sought Notice for Radiological and Nuclear Medical Countermeasures

Cleveland BioLabs Signs Term Sheet for Joint Venture to Develop Curaxin Compounds for Cancer Applications

Oncogene Publishes Cleveland BioLabs Paper on Mechanism of Action of Curaxins

Cleveland BioLabs Formally Terminates Boston Stock Exchange Listing

Cleveland BioLabs Updates Financial Condition Following Completion of Private Placement and Streamlining of Operations

Cleveland BioLabs Concludes Private Placement of Series D Preferred Stock and Common Stock Warrants

Form 4 CLEVELAND BIOLABS INC For: Dec 01 Filed by: Kogan Yakov (10K)

Form 4 CLEVELAND BIOLABS INC For: Nov 23 Filed by: Fonstein Michael (10K)

Form 4 CLEVELAND BIOLABS INC For: Nov 16 Filed by: Gudkov Andrei V (10K)

Form 4 Kogan Yakov For: Nov 02 (10K)

Form 4 CLEVELAND BIOLABS INC For: Oct 22 Filed by: Fonstein Michael (10K)

Form 4 CLEVELAND BIOLABS INC For: Oct 16 Filed by: Gudkov Andrei V (10K)

Form 4 Kogan Yakov For: Oct 01 (10K)

Form 4 Fonstein Michael For: Sep 22 (10K)

Form 4 Gudkov Andrei V For: Sep 16 (10K)

Form 4 Kogan Yakov For: Sep 01 (10K)